Triciferol |
Katalog-Nr.GC61947 |
Triciferol fungiert als Mehrfachligand mit kombinierten VDR-Agonisten- und HDAC-AntagonistenaktivitÄten. Triciferol bindet direkt an den VDR (IC50 = 87 nM) und wirkt als Agonist mit 1,25D-Ähnlicher Potenz auf mehrere 1,25D-Zielgene. Triciferol induziert eine ausgeprÄgte Tubulin-Hyperacetylierung und verstÄrkt die Histonacetylierung. Antiproliferative und zytotoxische AktivitÄten.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 957214-00-5
Sample solution is provided at 25 µL, 10mM.
Triciferol functions as a multiple ligand with combined VDR agonist and HDAC antagonist activities. Triciferol binds directly to the VDR (IC50=87 nM), and functions as an agonist with 1,25D-like potency on several 1,25D target genes. Triciferol induces marked tubulin hyperacetylation, and augments histone acetylation. Antiproliferative and cytotoxic activities[1].
Triciferol (0-10000 nM; 0-72 hours) is significantly more efficacious in suppressing the proliferation of estrogen receptor-negative human MDA-MB231 breast cancer cells[1].Treatment of MCF-7 cells with Triciferol (100-1000 nM) induces ≈2.5-fold higher rates of cell death than equimolar amounts of 1,25D[1].
References:
[1]. Tavera-Mendoza LE, et al. Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist. Proc Natl Acad Sci U S A. 2008;105(24):8250-8255.
Average Rating: 5
(Based on Reviews and 40 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *